Individualized Treatment Of Polycystic Ovary Syndrome: A Manifestation-Guided Practical Approach

March 2026 in “ Anti-Aging Eastern Europe ”

Plamena Kabakchieva

polycystic ovary syndrome PCOS hyperandrogenism insulin resistance combined oral contraceptives metformin letrozole antiandrogens GLP-1 receptor agonists inositols birth control pills Glucophage Femara glucagon-like peptide-1 receptor agonists

Studysummary This review examines current evidence on personalized management strategies for PCOS, but does not present new clinical results; the authors advocate for treatments tailored to predominant symptoms and individual health profiles.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on antiagingeeu.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Metformin Use in Women with Polycystic Ovary Syndrome: Opportunities, Benefits, and Clinical Challenges

May 2025 in “PubMed”

This review found that metformin improves insulin resistance, hormone levels, and menstrual regularity in non-pregnant women with PCOS, but is less effective for weight loss and ovulation induction.

Efficacy and Safety of Oral Minoxidil Versus Topical Solution in Androgenetic Alopecia: A Meta-Analysis of Randomized Clinical Trials

research Efficacy and Safety of Oral Minoxidil Versus Topical Solution in Androgenetic Alopecia: A Meta-Analysis of Randomized Clinical Trials

October 2024 in “International Journal of Dermatology”

In this meta-analysis, researchers found that oral and topical minoxidil treatments for androgenetic alopecia had similar efficacy in improving hair density and diameter, but oral minoxidil resulted in a higher incidence of hypertrichosis compared to topical use.

research Polycystic Ovary Syndrome: Diverse Clinical Presentations Across Adolescence, Reproductive Age, and Menopause

2 citations , June 2024 in “Anti-Aging Eastern Europe”

This review discusses the varied clinical presentations and management challenges of Polycystic Ovary Syndrome across different life stages, reporting no new clinical findings.

Bariatric Surgery for Spontaneous Ovulation in Women with Polycystic Ovary Syndrome: The BAMBINI Multicentre, Open-Label, Randomised Controlled Trial

research Bariatric Surgery for Spontaneous Ovulation in Women with Polycystic Ovary Syndrome: The BAMBINI Multicentre, Open-Label, Randomised Controlled Trial

4 citations , May 2024 in “The Lancet”

This study aims to compare the safety and effectiveness of bariatric surgery versus medical care on ovulation rates in women with PCOS and obesity, as current observational data suggests surgery may improve fertility prospects, but no randomized trial has yet confirmed this effect.

research Polycystic Ovary Syndrome

292 citations , April 2024 in “Nature Reviews Disease Primers”

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

research Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs

29 citations , September 2023 in “Journal of Clinical Medicine”

This study found that semaglutide significantly reduced body weight in almost 80% of obese PCOS patients unresponsive to lifestyle changes, often normalizing menstrual cycles with few side effects.

Efficacy and Safety of Anti-Androgens in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

research Efficacy and Safety of Anti-Androgens in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

7 citations , August 2023 in “EClinicalMedicine”

This study reported that anti-androgens combined with lifestyle modifications were more effective than metformin and lifestyle in reducing hirsutism and certain hormonal measures in women with PCOS, but they were not more effective than a placebo combined with lifestyle changes.

research Interventions for Female Pattern Hair Loss

21 citations , May 2016 in “The Cochrane library”

This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.

research The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report

1540 citations , October 2008 in “Fertility and Sterility”

This review discusses the definition of polycystic ovary syndrome proposed by the AE-PCOS Society Task Force, emphasizing hyperandrogenism, ovarian dysfunction, and excluding related disorders, while noting potential variations needing more research.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

This review discusses the evolution of diagnostic criteria for polycystic ovary syndrome and emphasizes its association with various metabolic and cardiovascular risks, but it provides no new research findings.

research Clinical and Hormonal Effects of the 5 Alpha-Reductase Inhibitor Finasteride in Idiopathic Hirsutism

33 citations , October 1994 in “The Journal of Clinical Endocrinology and Metabolism”

This study found that finasteride treatment significantly reduced hirsutism scores in women with idiopathic hirsutism over 6 months and was well tolerated.